Lucid Diagnostics Inc.
LUCD
Nasdaq
Manufacturing
Measuring & Analyzing Instruments
$1.14
▲
$0.02
(1.34%)
Mkt Cap: 193.36 M
Price
$1.14
Mkt Cap
193.36 M
Day Range
$1.13 — $1.16
52-Week Range
$0.95 — $1.70
Volume
318,831
Open $1.13
50D / 200D Avg
$1.29
12.12% below
50D / 200D Avg
$1.16
2.17% below
Price History
Financial Trends
No fundamental snapshot available yet.
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | 4.35 M | 2.43 M | 377,000.0 | 500,000.0 |
| Net Income | -58.01 M | -45.53 M | -52.67 M | -56.17 M | -28.08 M |
| EPS (Diluted) | — | -1.05 | -1.26 | — | — |
| Gross Profit | — | — | — | 377,000.0 | -85,000.0 |
| Operating Income | -49.64 M | -46.05 M | -48.48 M | -56.17 M | -27.42 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 5.68 M | 5.99 M | 7.25 M | 11.47 M | 9.30 M |
| SG&A Expenses | — | — | — | 21,000.0 | 21,000.0 |
| D&A | 872,000.0 | 1.17 M | 2.50 M | 1.94 M | — |
| Interest Expense | 22,000.0 | 26,000.0 | 416,000.0 | 659,000.0 | 659,000.0 |
| Income Tax | 0.0 | — | — | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 40.45 M | 30.72 M | 27.27 M | 32.51 M | 59.00 M |
| Total Liabilities | 29.51 M | 25.32 M | 29.58 M | 9.46 M | 4.26 M |
| Shareholders' Equity | 10.94 M | 5.39 M | -2.31 M | 23.05 M | 54.74 M |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | — | 22.36 M | 18.90 M | 22.47 M | — |
| Current Assets | 37.47 M | 25.15 M | 22.07 M | 24.36 M | 57.30 M |
| Current Liabilities | 28.58 M | 23.52 M | 29.38 M | 8.43 M | — |
{"event":"ticker_viewed","properties":{"ticker":"LUCD","listing_kind":"stock","pathname":"/stocks/lucd","exchange":"Nasdaq","country":"US"}}